NPJP Stock Chart & Stats
€4.20
€0.02(1.33%)
At close: 4:00 PM EST
€4.20
€0.02(1.33%)
Day’s Range― - ―
52-Week Range€2.32 - €5.00
Previous CloseN/A
Volume0.00
Average Volume (3M)1.00
Market Cap
€34.54M
Enterprise Value€29.70
Total Cash (Recent Filing)€4.02M
Total Debt (Recent Filing)€968.00K
Price to Earnings (P/E)51.4
Beta-0.17
Next Earnings
Aug 12, 2026Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.07
Shares Outstanding10,856,546
10 Day Avg. Volume3
30 Day Avg. Volume1
Financial Highlights & Ratios
PEG Ratio0.03
Price to Book (P/B)5.08
Price to Sales (P/S)2.76
P/FCF Ratio31.48
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
€7.01Price Target Upside66.82% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1
EPS Forecast (FY)0.05
Revenue Forecast (FY)€17.69M
Bulls Say, Bears Say
Bulls Say
Conservative Balance SheetLow leverage and an equity base that has grown over time provide durable financial flexibility. Being essentially debt-light reduces refinancing and interest risks, supporting continued investments in installations, services, and geographic expansion during multi-quarter scale-up efforts.
Recurring Installed-base GrowthStrong programmatic growth and an expanding installed base create predictable recurring revenue from replacements and services. That installed-base-driven consumable demand supports durable revenue visibility, improves lifetime customer value, and underpins margin recovery as scale and reorders rise.
Addressable Market & Services ExpansionMoving into larger commercial end-markets while building services and education diversifies TAM and reduces dependence on episodic emergency sales. Service-led adoption and training increase customer retention and recurring revenue potential, supporting more stable long-term unit economics.
Bears Say
Weak Cash GenerationA reversal to negative operating and free cash flow raises sustainability concerns: continued cash burn can force trade-offs between working-capital needs, inventory refresh, and investment in growth initiatives. This constrains capital flexibility over several quarters if cash conversion doesn't improve.
Gross Margin CompressionAn 8ppt gross margin drop driven by tariffs, FX and lower-margin product mix undermines durable profitability. If tariff/FX impacts or a structural shift toward lower-margin commercial products persist, margin recovery will depend on cost mitigation and product mix management over multiple quarters.
Rising Operating Expenses & Profit DeclineMaterial profit and EBITDA declines alongside rising R&D and SG&A reflect weaker earnings leverage. Sustained higher operating expense levels for expansion efforts can prolong cash burn and compress returns unless top-line growth and margin mix improvements outpace expense growth over the medium term.
NPJP FAQ
What was Nephros Inc’s price range in the past 12 months?
Nephros Inc lowest stock price was €2.32 and its highest was €5.00 in the past 12 months.
What is Nephros Inc’s market cap?
Nephros Inc’s market cap is €34.54M.
When is Nephros Inc’s upcoming earnings report date?
Nephros Inc’s upcoming earnings report date is Aug 12, 2026 which is in 26 days.
How were Nephros Inc’s earnings last quarter?
Nephros Inc released its earnings results on May 07, 2026. The company reported €0.009 earnings per share for the quarter, the consensus estimate of €0.009 by €0.
Is Nephros Inc overvalued?
According to Wall Street analysts Nephros Inc’s price is currently Undervalued.
Does Nephros Inc pay dividends?
Nephros Inc does not currently pay dividends.
What is Nephros Inc’s EPS estimate?
Nephros Inc’s EPS estimate is 0.
How many shares outstanding does Nephros Inc have?
Nephros Inc has 10,856,546 shares outstanding.
What happened to Nephros Inc’s price movement after its last earnings report?
Nephros Inc reported an EPS of €0.009 in its last earnings report, expectations of €0.009. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Nephros Inc?
Currently, no hedge funds are holding shares in DE:NPJP
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Nephros Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Positive
20 days / 200 days
Momentum
213.80%
12-Months-Change
Fundamentals
Return on Equity
7.66%
Trailing 12-Months
Asset Growth
17.12%
Trailing 12-Months
Company Description
Nephros Inc
Nephros, Inc. is a company that specializes in developing and marketing sophisticated water purification solutions across the United States, catering to both the medical and commercial sectors. Its operations are structured into three primary segments: Water Filtration, Pathogen Detection, and Renal Products. Within its Water Filtration division, Nephros offers advanced ultrafiltration products. These are vital in dialysis centers for eradicating biological contaminants from water and bicarbonate concentrate, and are also deployed in hospitals to prevent infections from waterborne pathogens such as Legionella and Pseudomonas. Their utility extends to military installations, outdoor recreation, commercial establishments, and various other healthcare facilities. The Pathogen Detection segment focuses on developing and distributing real-time water testing systems, which deliver critical, actionable data regarding waterborne pathogens. Furthermore, under its Renal Products segment, the company provides medical devices designed for individuals suffering from renal disease, notably including a second-generation hemodiafiltration system tailored for patients with end-stage renal disease. Additionally, Nephros markets a range of water filters under the Nephros and AETHER brands. These filters are engineered not only to enhance water taste and eliminate odors but also to significantly reduce biofilm, bacteria, and scale accumulation in downstream equipment, serving the food service, hospitality, convenience store, and healthcare industries. Established in 1997, Nephros, Inc. maintains its corporate headquarters in South Orange, New Jersey.
NPJP Stock 12 Month Forecast
Average Price Target
€7.01
▲(66.82% Upside)









